<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK299311" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK299311/" /><meta name="ncbi_pagename" content="ACTG2-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ACTG2-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ACTG2-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/06/11" /><meta name="citation_author" content="Michael F Wangler" /><meta name="citation_author" content="Arthur L Beaudet" /><meta name="citation_pmid" content="26072522" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK299311/" /><meta name="citation_keywords" content="Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome" /><meta name="citation_keywords" content="Prune Belly Sequence" /><meta name="citation_keywords" content="Chronic Intestinal Pseudoobstruction (CIPO)" /><meta name="citation_keywords" content="Actin, gamma-enteric smooth muscle" /><meta name="citation_keywords" content="ACTG2" /><meta name="citation_keywords" content="ACTG2-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ACTG2-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Michael F Wangler" /><meta name="DC.Contributor" content="Arthur L Beaudet" /><meta name="DC.Date" content="2015/06/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK299311/" /><meta name="description" content="ACTG2-related disorders are a subset of visceral myopathy with variable involvement of the bladder and intestine. Bladder involvement can range from neonatal megacystis and megaureter (with its most extreme form of prune belly syndrome) at the more severe end, to recurrent urinary tract infections and bladder dysfunction at the milder end. Chronic bladder dysfunction carries a high risk for urinary tract infections, dilation of the upper urinary tract, and impaired renal function. Intestinal involvement can range from malrotation, neonatal manifestations of microcolon, megacystic microcolon intestinal hypoperistalsis syndrome (MMIHS), and chronic intestinal pseudoobstruction (CIPO) in neonates, children, and adults. Affected infants (with or without evidence of intestinal malrotation) often present with feeding intolerance and findings of non-mechanical bowel obstruction that persist after successful surgical correction of malrotation. Individuals who develop manifestations of CIPO in later childhood or adulthood often experience episodic waxing and waning of bowel motility. They may undergo frequent abdominal surgeries (perhaps related to malrotation or adhesions causing mechanical obstruction) resulting in resection of dilated segments of bowel, often becoming dependent on total parenteral nutrition (TPN)." /><meta name="og:title" content="ACTG2-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="ACTG2-related disorders are a subset of visceral myopathy with variable involvement of the bladder and intestine. Bladder involvement can range from neonatal megacystis and megaureter (with its most extreme form of prune belly syndrome) at the more severe end, to recurrent urinary tract infections and bladder dysfunction at the milder end. Chronic bladder dysfunction carries a high risk for urinary tract infections, dilation of the upper urinary tract, and impaired renal function. Intestinal involvement can range from malrotation, neonatal manifestations of microcolon, megacystic microcolon intestinal hypoperistalsis syndrome (MMIHS), and chronic intestinal pseudoobstruction (CIPO) in neonates, children, and adults. Affected infants (with or without evidence of intestinal malrotation) often present with feeding intolerance and findings of non-mechanical bowel obstruction that persist after successful surgical correction of malrotation. Individuals who develop manifestations of CIPO in later childhood or adulthood often experience episodic waxing and waning of bowel motility. They may undergo frequent abdominal surgeries (perhaps related to malrotation or adhesions causing mechanical obstruction) resulting in resection of dilated segments of bowel, often becoming dependent on total parenteral nutrition (TPN)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK299311/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/actg2-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK299311/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88DCB3E03FCDC1000000000627023A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK299311_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK299311_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dupl22q11/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/adamtsl4-eyes/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK299311_"><span class="title" itemprop="name"><i>ACTG2</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Michael F Wangler</span>, MD and <span itemprop="author">Arthur L Beaudet</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK299311_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK299311_ai__"><div class="contrib half_rhythm"><span itemprop="author">Michael F Wangler</span>, MD<div class="affiliation small">Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@relgnaw.leahcim" class="oemail">ude.mcb@relgnaw.leahcim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Arthur L Beaudet</span>, MD<div class="affiliation small">Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@teduaeba" class="oemail">ude.mcb@teduaeba</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 11, 2015</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="actg2-dis.Summary" itemprop="description"><h2 id="_actg2-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characeristics.</h4><p><i>ACTG2</i>-related disorders are a subset of visceral myopathy with variable involvement of the bladder and intestine. Bladder involvement can range from neonatal megacystis and megaureter (with its most extreme form of prune belly syndrome) at the more severe end, to recurrent urinary tract infections and bladder dysfunction at the milder end. Chronic bladder dysfunction carries a high risk for urinary tract infections, dilation of the upper urinary tract, and impaired renal function. Intestinal involvement can range from malrotation, neonatal manifestations of microcolon, megacystic microcolon intestinal hypoperistalsis syndrome (MMIHS), and chronic intestinal pseudoobstruction (CIPO) in neonates, children, and adults. Affected infants (with or without evidence of intestinal malrotation) often present with feeding intolerance and findings of non-mechanical bowel obstruction that persist after successful surgical correction of malrotation. Individuals who develop manifestations of CIPO in later childhood or adulthood often experience episodic waxing and waning of bowel motility. They may undergo frequent abdominal surgeries (perhaps related to malrotation or adhesions causing mechanical obstruction) resulting in resection of dilated segments of bowel, often becoming dependent on total parenteral nutrition (TPN).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of an <i>ACTG2</i>-related disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ACTG2.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management requires a multidisciplinary approach that includes primary care providers, gastroenterologists, general surgeons, urologists, nephrologists, dieticians, and social workers. Chronic bladder dysfunction typically requires management by a urologist and can involve routine urinary catheterization or diversion to reduce the risk of dilation of the upper urinary tract and associated risk for urinary tract infection and renal functional impairment. CIPO typically requires management by a gastroenterologist and nutritionist familiar with intestinal motility disorders.</p><p><i>Prevention of secondary complications:</i> Clean and safe practices in the use of indwelling intravenous catheters for administration of TPN and bladder catheterization can help prevent infections. Surgical procedures associated with general anesthesia can produce a post-surgical ileus which can persist for an extended period.</p><p><i>Surveillance:</i> Should be individualized taking into account:</p><ul><li class="half_rhythm"><div>The association between urinary tract infections and chronic bladder dysfunction and the increased risk for dilation of the upper urinary tract, and renal functional impairment</div></li><li class="half_rhythm"><div>Need for routine evaluation of liver function in those dependent on long-term TPN.</div></li></ul><p><i>Agents/circumstances to avoid:</i> For those with CIPO, high-fat foods (&#x0003e;30% of total calories) and consumption of lactose and fructose may worsen abdominal bloating and discomfort.</p><p><i>Evaluation of relatives at risk:</i> Presymptomatic diagnosis and treatment is warranted in relatives at risk as early diagnosis may help prevent unnecessary surgery for symptoms of intestinal obstruction and may allow early evaluation of bladder function, the urinary tract (for evidence of dilation), and renal function.</p><p><i>Pregnancy management:</i> When a fetus at risk for an <i>ACTG2</i>-related disorder has evidence of bladder distention on prenatal ultrasound examination, consultation with a maternal fetal medicine specialist is recommended.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ACTG2-</i>related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. While the exact proportion of inherited vs <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown, current data suggest that <i>de novo</i> pathogenic variants are common. Each child of an individual with an <i>ACTG2</i>-related disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Although <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>ACTG2</i>-related disorders appears to be complete, the severity of clinical findings can vary within a family. Prenatal testing for pregnancies at increased risk is possible if the <i>ACTG2</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="actg2-dis.GeneReview_Scope"><h2 id="_actg2-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="actg2-dis.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299311/table/actg2-dis.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__actg2-dis.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_actg2-dis.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>ACTG2</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_actg2-dis.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS)</div></li><li class="half_rhythm"><div>Prune belly sequence</div></li><li class="half_rhythm"><div>Chronic intestinal pseudoobstruction (CIPO)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#actg2-dis.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="actg2-dis.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#actg2-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="actg2-dis.Diagnosis"><h2 id="_actg2-dis_Diagnosis_">Diagnosis</h2><p><i>ACTG2</i>-related disorders are a subset of visceral myopathy with variable involvement of the bladder and intestine.</p><div id="actg2-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>ACTG2</i>-related disorders <b>should be suspected</b> in individuals with bladder and/or intestinal involvement that can range in a continuum from severe in neonates to more mild in older children and adults.</p><p><b>Bladder involvement</b> can range from neonatal megacystis and megaureter (with its most extreme form of prune belly syndrome) at the more severe end to recurrent urinary tract infections and bladder dysfunction at the milder end. Chronic bladder dysfunction has a high risk of urinary tract infections, dilation of the upper urinary tract, and impaired renal function.</p><p>Suggestive bladder findings:</p><ul><li class="half_rhythm"><div>Prenatal ultrasound revealing megacystis, defined according to trimester [<a class="bk_pop" href="#actg2-dis.REF.fievet.2014.185">Fievet et al 2014</a>]:</div><ul><li class="half_rhythm"><div>First trimester: bladder diameter &#x0003e;6 mm</div></li><li class="half_rhythm"><div>Second and third trimesters: enlarged bladder with failure to empty within 45 minutes</div></li></ul></li><li class="half_rhythm"><div>In neonates: prune-belly sequence (megacystis with lack of abdominal wall musculature, cryptorchidism in males, and distention of the upper urinary tract) in association with impaired gastrointestinal motility</div></li><li class="half_rhythm"><div>Postnatal ultrasound examination or cystogram revealing an enlarged bladder</div></li><li class="half_rhythm"><div>In individuals of any age: unexplained chronic functional bladder impairment of voiding without mechanical blockage</div></li></ul><p><b>Intestinal involvement</b> can range from malrotation, neonatal manifestations of microcolon, and megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) to chronic intestinal pseudoobstruction (CIPO) in neonates, infants, children, and adults.</p><p>Suggestive intestinal findings:</p><ul><li class="half_rhythm"><div>Neonatal bilious emesis, abdominal distention, and feeding intolerance</div></li><li class="half_rhythm"><div>Intestinal malrotation and long-term intestinal motility problems often resulting in chronic abdominal pain and constipation</div></li><li class="half_rhythm"><div>Neonatal microcolon</div></li><li class="half_rhythm"><div>In individuals of any age: chronic intestinal pseudoobstruction (CIPO) (i.e., unexplained chronic functional intestinal obstruction involving small bowel and/or colon without evidence of mechanical blockage).</div></li></ul><p>Suggested specific diagnostic findings [<a class="bk_pop" href="#actg2-dis.REF.gabbard.2013.307">Gabbard &#x00026; Lacy 2013</a>]:</p><ul><li class="half_rhythm"><div>Symptoms lasting &#x0003e;6 months, or &#x0003e;2 months from birth</div></li><li class="half_rhythm"><div>Evidence of delayed GI transit and/or decreased GI motility</div></li><li class="half_rhythm"><div>Imaging studies that do not show mechanical obstruction</div></li><li class="half_rhythm"><div>Radiographic documentation of dilated bowel, air fluid levels without fixed obstruction [<a class="bk_pop" href="#actg2-dis.REF.rudolph.1997.102">Rudolph et al 1997</a>]</div></li></ul></div><div id="actg2-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of an <i>ACTG2</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ACTG2</i> (see <a class="figpopup" href="/books/NBK299311/table/actg2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figactg2disTmoleculargenetictestingus" rid-ob="figobactg2disTmoleculargenetictestingus">Table 1</a>).</p><p>Between 50% and 70% of individuals with a clinical diagnosis of MMIHS and a significant but unknown fraction of individuals with a diagnosis of CIPO have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>.</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ACTG2</i> is performed first. Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis may be considered if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found; however, all pathogenic variants identified to date are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, and no <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications have been identified as a cause of <i>ACTG2</i>-related disorders.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ACTG2</i> and other genes of interest (see <a href="#actg2-dis.Differential_Diagnosis">Differential Diagnosis</a>) may also be used. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="actg2-dis.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ACTG2</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299311/table/actg2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__actg2-dis.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACTG2</i></td><td headers="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23/23&#x000a0;<sup>3,&#x000a0;4</sup></td></tr><tr><td headers="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_actg2-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None detected to date</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="actg2-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK299311/#actg2-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#actg2-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="actg2-dis.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="actg2-dis.TF.1.3"><p class="no_margin">2/2 probands in <a class="bk_pop" href="#actg2-dis.REF.thorson.2014.737">Thorson et al [2014]</a>, 15/15 probands with <i>ACTG2</i>-related disorders in <a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al [2014]</a>, 3/3 probands in <a class="bk_pop" href="#actg2-dis.REF.tuzovic.2015.296">Tuzovic et al [2015]</a>, the case/family reports of <a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al [2012]</a>, <a class="bk_pop" href="#actg2-dis.REF.holla.2014.533">Holla et al [2014]</a>, and <a class="bk_pop" href="#actg2-dis.REF.klar.2015.1679">Klar et al [2015]</a></p></div></dd><dt>4. </dt><dd><div id="actg2-dis.TF.1.4"><p class="no_margin">All pathogenic variants identified to date are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>.</p></div></dd><dt>5. </dt><dd><div id="actg2-dis.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, and multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="actg2-dis.Clinical_Characteristics"><h2 id="_actg2-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="actg2-dis.Clinical_Description"><h3>Clinical Description</h3><p>A number of clinical phenotypes characterized by smooth muscle dysfunction affecting bowel and bladder (including diagnoses such as megacystis-microcolon-intestinal hypoperistalsis syndrome [MMIHS] and chronic intestinal pseudoobstruction [CIPO]) have been described and reported in detail [<a class="bk_pop" href="#actg2-dis.REF.puri.2005.58">Puri &#x00026; Shinkai 2005</a>]. At this time it is not known what percentage of the phenotypes reported before 2012 were caused by mutation of <i>ACTG2</i> versus other causes.</p><div id="actg2-dis.Molecularly_Confirmed_ACTG2Rel"><h4>Molecularly Confirmed <i>ACTG2</i>-Related Disorders</h4><p>Because <i>ACTG2</i> pathogenic variants have only recently been identified as a cause of MMIHS, CIPO, and similar phenotypes, the number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date is small [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>, <a class="bk_pop" href="#actg2-dis.REF.holla.2014.533">Holla et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.thorson.2014.737">Thorson et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>]. (See <a class="figpopup" href="/books/NBK299311/table/actg2-dis.T.summary_of_bladder_and_intes/?report=objectonly" target="object" rid-figpopup="figactg2disTsummaryofbladderandintes" rid-ob="figobactg2disTsummaryofbladderandintes">Table 2</a>.) Thus, current understanding of the breadth of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and natural history of <i>ACTG2</i>-related disorders is limited, but expected to evolve over time.</p><p>Individuals with an <i>ACTG2</i>-related disorder experience functional defects of smooth muscle involving both bladder and bowel. General clinical patterns include neonates with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who experience severe functional impairment of bowel and bladder consistent with MMIHS, and individuals with an inherited (<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>) <i>ACTG2</i> pathogenic variant who experience later-onset CIPO. Individuals with <i>ACTG2</i>-related disorders usually have normal intellect.</p><div id="actg2-dis.T.summary_of_bladder_and_intes" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Summary of Bladder and Intestinal Findings in Individuals with Molecularly Confirmed <i>ACTG2</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299311/table/actg2-dis.T.summary_of_bladder_and_intes/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__actg2-dis.T.summary_of_bladder_and_intes_lrgtbl__"><table><thead><tr><th id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" style="text-align:left;vertical-align:middle;">Finding</th><th id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2" colspan="5" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;"># Reported by Study</th></tr><tr><th headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2" id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#actg2-dis.REF.sipponen.2009.437">Sipponen et al [2009]</a>, <a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al [2012]</a></th><th headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2" id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#actg2-dis.REF.thorson.2014.737">Thorson et al [2014]</a></th><th headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2" id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#actg2-dis.REF.holla.2014.533">Holla et al [2014]</a></th><th headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2" id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al [2014]</a></th><th headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2" id="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#actg2-dis.REF.klar.2015.1679">Klar et al [2015]</a></th></tr></thead><tbody><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Bladder</b></td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prenatal or postnatal megacystis</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not Reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Prune belly syndrome</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not Reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Chronic functional impairment</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not Reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Intestinal</b></td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microcolon</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not Reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Bilious emesis or inability to tolerate feeds as a neonate</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not Reported</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">History of abdominal surgery</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dependent on parenteral nutrition</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (intermittent)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CIPO</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b><i>De novo</i> cases (# of families)</b></td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (2)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (10)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Dominant <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases (# of families)</b></td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8 (1)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (1)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (3)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (1)</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Undetermined inheritance cases (# of families)</b></td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (2)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (0)</td></tr><tr><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total molecularly confirmed cases (total # of families)</b></td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8 (1)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (2)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (1)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21 (15)</td><td headers="hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_1_2 hd_h_actg2-dis.T.summary_of_bladder_and_intes_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (1)</td></tr></tbody></table></div></div><p><b>Urologic.</b> From a recent series the majority of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had prenatal or postnatal megacystis and approximately one third had had a vesicoamniotic shunt placed prenatally [<a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>].</p><p>Prune belly syndrome, characterized by lack of abdominal wall musculature, cryptorchidism in males, and distention of the urinary tract, was reported in one male with MMIHS and a <i>de novo ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>].</p><p>Chronic bladder functional impairment seen in the majority of individuals with an <i>ACTG2</i>
<a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can require lifelong bladder catheterization.</p><p><b>Gastrointestinal.</b> The majority of neonates with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are unable to tolerate feedings. Likewise, intestinal malrotation is common and while many undergo a Ladd surgical procedure, many experience persistent symptoms of bowel obstruction after surgical recovery [<a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>].</p><p>Affected individuals can experience episodic improvement of bowel motility, loss of bowel motility over time, or waxing and waning of reduced bowel motility. Affected individuals may undergo frequent abdominal surgeries (perhaps related to malrotation or presumed adhesions causing mechanical obstruction) resulting in resection of dilated segments of bowel.</p><p>In many families with a dominantly inherited <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and waxing and waning CIPO, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals report lifelong gastrointestinal discomfort and symptoms with episodes resulting in surgery and hospitalization. These individuals can survive to an advanced age.</p><p><b>Long-term survival.</b> Long-term survival in those with a <i>de novo ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> usually requires total parenteral nutrition and urinary catheterization or diversion. Most long-term survivors have ileostomies.</p><p>Large series of individuals with MMIHS reported before the molecular basis of <i>ACTG2</i>-related disorders was known suggested that long-term survival was uncommon because the majority die in childhood or infancy of sepsis, organ failure, and/or malnutrition [<a class="bk_pop" href="#actg2-dis.REF.gosemann.2011.1041">Gosemann &#x00026; Puri 2011</a>]. In contrast, in families with an inherited <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, some family members with the pathogenic variant have MMIHS and others with the same variant have milder phenotypes, living into adolescence and early adulthood [<a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>].</p><p>It is not clear whether differences in prognosis for individuals with an <i>ACTG2-</i>related disorder compared to those with MMIHS of unknown cause reflect advances in medical management of parenteral nutrition or other factors.</p></div><div id="actg2-dis.Smooth_Muscle_Dysfunction_incl"><h4>Smooth Muscle Dysfunction (including MMIHS and CIPO) of Unknown Cause</h4><p>Several studies have explored the clinical features of individuals with MMIHS and CIPO, but the proportion due to an <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> versus other causes is not known. Therefore, these studies may encompass patient populations that combine <i>ACTG2</i>-related disorders and those of other etiologies.</p><p><b>Urologic.</b> Prenatal ultrasound examination is reported to identify megacystis in 88% and gastrointestinal abnormalities in 24% [<a class="bk_pop" href="#actg2-dis.REF.tuzovic.2014.74">Tuzovic et al 2014</a>].</p><p>Radiographic studies after delivery could reveal megacystis, hydronephrosis, vesicoureteral reflux, and/or the presence of microcolon [<a class="bk_pop" href="#actg2-dis.REF.ballisty.2013.454">Ballisty et al 2013</a>].</p><p>Although urinary obstruction and its potential adverse effect on renal function are often a concern in individuals with MMIHS, the long-term consequences for kidney function are not known. In one report of 709 individuals with fetal dilation of the urinary tract of diverse causes (e.g., posterior urethral valves and other types of mechanical obstruction not consistent with MMIHS), 17 instances of MMIHS were identified among 98 individuals with megacystis [<a class="bk_pop" href="#actg2-dis.REF.alhazmi.2012.649">Al-Hazmi et al 2012</a>]. In this series, almost 30% (86/289) of those with severe fetal urinary tract dilatation had an abnormal serum creatinine concentration at age two years.</p><p><b>Gastrointestinal.</b> Chronic intestinal pseudoobstruction (CIPO) has been reported at ages ranging from infancy to adulthood. After onset, progression to severe digestive dysfunction can range from one to 46 years [<a class="bk_pop" href="#actg2-dis.REF.de_giorgio.2011.787">De Giorgio et al 2011</a>].</p><p>Some individuals with CIPO may undergo exploratory laparotomy without identification of an obstructive lesion.</p><p><b>Pathology.</b> Numerous histopathologic studies on infants with MMIHS have had variable or inconsistent results [<a class="bk_pop" href="#actg2-dis.REF.puri.2005.58">Puri &#x00026; Shinkai 2005</a>]. Findings have included alterations in ganglion cells (rare), vacuolar degeneration in the smooth muscle layer with connective tissue infiltration between muscle cells in bowel and bladder, excess muscle glycogen, and absent or reduced smooth muscle actin [<a class="bk_pop" href="#actg2-dis.REF.puri.2005.58">Puri &#x00026; Shinkai 2005</a>].</p><p>Visceral myopathy reveals the presence of vacuoles or fibrous replacement in the smooth muscle layer (muscularis propria) in a full-thickness intestinal biopsy [<a class="bk_pop" href="#actg2-dis.REF.huang.2013b.699">Huang et al 2013b</a>].</p></div></div><div id="actg2-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified.</p><p>To date all reported <i>ACTG2</i> pathogenic variants have been <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, many of which affect arginine residues of the &#x003b3;-2 actin protein. The same missense variants have been seen across the phenotypic spectrum from neonatal MMIHS to later-onset chronic intestinal pseudoobstruction. Of note, disease caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is often more severe than inherited disease.</p><p>Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants may be benign; however, this is not known with certainty.</p></div><div id="actg2-dis.Penetrance"><h3>Penetrance</h3><p>Thus far, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>ACTG2-</i>related disorders appears to be complete, as no family members <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a known <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been noted to be completely symptom free. However, the clinical severity can range within a family, and mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may not be aware of the diagnosis. Examples: (1) one individual (in a multi-generation Finnish family) with an <i>ACTG2</i> pathogenic variant reported episodic mild abdominal pain but no surgery and no signs of visceral myopathy at age 19 years [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>]; (2) one individual diagnosed with "spastic colon" and irritable bowel syndrome had not required surgery or intervention in middle age [<a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>].</p></div><div id="actg2-dis.Nomenclature"><h3>Nomenclature</h3><p>Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) may also be referred to as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> visceral myopathy or Berdon syndrome.</p><p>The broad term "hollow visceral myopathy" includes phenotypically related disorders caused by pathogenic variants in other genes (e.g., <i>ACTA2</i>), and, therefore, should not be used as a synonym for <i>ACTG2</i>-related disorders [<a class="bk_pop" href="#actg2-dis.REF.milewicz.2010.2437">Milewicz et al 2010</a>].</p><p>Prune belly sequence may also be referred to as Eagle-Barrett syndrome.</p></div><div id="actg2-dis.Prevalence"><h3>Prevalence</h3><p>To date 47 individuals (from 23 families) have been reported to have a molecularly confirmed <i>ACTG2</i>-related disorder [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>, <a class="bk_pop" href="#actg2-dis.REF.holla.2014.533">Holla et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.thorson.2014.737">Thorson et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>]. (See <a class="figpopup" href="/books/NBK299311/table/actg2-dis.T.summary_of_bladder_and_intes/?report=objectonly" target="object" rid-figpopup="figactg2disTsummaryofbladderandintes" rid-ob="figobactg2disTsummaryofbladderandintes">Table 2</a>.)</p><p>A total of 227 individuals with MMIHS were reported between 1976 and 2011 [<a class="bk_pop" href="#actg2-dis.REF.gosemann.2011.1041">Gosemann &#x00026; Puri 2011</a>]. The proportion with an <i>ACTG2</i>-related disorder is unknown.</p><p>It is estimated that 100 individuals per year in the United States are diagnosed with CIPO [<a class="bk_pop" href="#actg2-dis.REF.de_giorgio.2011.787">De Giorgio et al 2011</a>]. The proportion with an <i>ACTG2</i>-related disorder is unknown.</p></div></div><div id="actg2-dis.Genetically_Related_Allelic_Di"><h2 id="_actg2-dis_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>ACTG2</i>.</p></div><div id="actg2-dis.Differential_Diagnosis"><h2 id="_actg2-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p>Since many individuals with visceral myopathy with variable involvement of the bladder and intestine do not have an <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, mutation of other genes must contribute to the etiology of this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<a class="figpopup" href="/books/NBK299311/table/actg2-dis.T.inherited_disorders_in_the_d/?report=objectonly" target="object" rid-figpopup="figactg2disTinheriteddisordersinthed" rid-ob="figobactg2disTinheriteddisordersinthed">Table 3</a>). Because mydriasis has been noted in some individuals with MMIHS (megacystis-microcolon-intestinal hypoperistalsis syndrome) [<a class="bk_pop" href="#actg2-dis.REF.mcclelland.2013.271">McClelland et al 2013</a>] but not in those with an <i>ACTG2</i>-related disorder, the presence of mydriasis may suggest a differ disorder.</p><div id="actg2-dis.T.inherited_disorders_in_the_d" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Inherited Disorders in the Differential Diagnosis for <i>ACTG2</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299311/table/actg2-dis.T.inherited_disorders_in_the_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__actg2-dis.T.inherited_disorders_in_the_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe GI or GU Involvement or Both</th><th id="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Clinical Features</th></tr></thead><tbody><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYH11</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Both</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Patent ductus arteriosus in 1 individual</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACTA2</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Both</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vascular aneurysms &#x00026; dissections, patent ductus arteriosus, mydriasis</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLNA</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GI</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Periventricular heterotopia in males, seizures in females</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TYMP</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GI</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mngie/">MNGIE</a>: ptosis, ophthalmoplegia &#x00026; ophthalmoparesis, hearing loss, neuropathy</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EDNRB</i>, <i>EDN3</i>, or <i>SOX10</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD or AR</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GI</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Waardenburg syndrome w/pigmentary abnormalities</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SGOL1</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GI</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAID: sick sinus syndrome, atrial dysrhythmias</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAD21</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GI</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mungan syndrome: Barrett esophagus, megaduodenum, cardiac abnormalities</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRM3</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GU</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior urethral valves &#x00026; prune belly syndrome</td></tr><tr><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNA3, CHRNB2, CHRNB4</i></td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GU</td><td headers="hd_h_actg2-dis.T.inherited_disorders_in_the_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mouse models w/mydriasis &#x00026; megacystis</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CAID = chronic atrial and intestinal dysrhythmia; GI = gastrointestinal; GU = genitourinary; MNGIE = mitochondrial neurogastrointestinal encephalopathy; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; NA = not applicable; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd></dl></div></div></div><p><b><i>MYH11</i></b>. Mutation of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> was identified in a child with MMIHS and patent ductus arteriosus [<a class="bk_pop" href="#actg2-dis.REF.gauthier.2015.1266">Gauthier et al 2015</a>].</p><p><b><i>ACTA2</i>.</b> This multisystemic smooth muscle dysfunction syndrome due to a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>ACTA2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is characterized by dysfunction of smooth muscle cells throughout the body, leading to severe and highly penetrant vascular diseases that include <a href="/books/n/gene/taa/">thoracic aortic aneurysms and aortic dissections</a>, patent ductus arteriosus, stenosis and dilatation of cerebral vessels, mydriasis, periventricular white matter hyperintensities on MRI, and pulmonary hypertension, as well as features characteristic of <i>ACTG2</i>-related disorders such as hypotonic bladder and malrotation and hypo-peristalsis of the gut [<a class="bk_pop" href="#actg2-dis.REF.milewicz.2010.2437">Milewicz et al 2010</a>]. Prune-belly sequence can also be associated [<a class="bk_pop" href="#actg2-dis.REF.richer.2012.664">Richer et al 2012</a>].</p><p><b><i>FLNA</i>.</b> Pathogenic variants in this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> have been reported in association with intestinal pseudoobstruction, as well as its commonly recognized phenotypes: <a href="/books/n/gene/x-pvh/">X-linked periventricular heterotopia</a>, a neuronal migration disorder with early lethality in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and seizures in affected females [<a class="bk_pop" href="#actg2-dis.REF.gargiulo.2007.751">Gargiulo et al 2007</a>, <a class="bk_pop" href="#actg2-dis.REF.kapur.2010.1528">Kapur et al 2010</a>].</p><p><b><i>TYMP</i>.</b>
<a href="/books/n/gene/mngie/">Mitochondrial neurogastrointestinal encephalopathy</a> (MNGIE) disease is characterized by: progressive gastrointestinal dysmotility and cachexia manifesting as early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain and/or distention, and diarrhea; ptosis/ophthalmoplegia or ophthalmoparesis; hearing loss; and demyelinating peripheral neuropathy manifesting as paresthesias (tingling, numbness, and pain) and symmetric and distal weakness more prominently affecting the lower extremities. The order in which manifestations appear is unpredictable. Onset is usually between the first and fifth decades. Direct evidence of MNGIE disease is provided by increase in plasma thymidine concentration &#x0003e;3 &#x000b5;mol/L and increase in plasma deoxyuridine concentration &#x0003e;5 &#x000b5;mol/L.</p><p><b><i>SGOL1</i>.</b> Chronic atrial and intestinal dysrhythmia (CAID) is the constellation of sick sinus syndrome (SSS) with aberrant sinus node pacing in the heart and intestinal pseudoobstruction [<a class="bk_pop" href="#actg2-dis.REF.chetaille.2014.1245">Chetaille et al 2014</a>]. Bladder involvement was not reported. Atrial dysrhythmias have not been observed in <i>ACTG2-</i> related disorders.</p><p><b><i>RAD21.</i></b>
<i>T</i>he combination of CIPO, Barrett esophagus, and cardiac abnormalities caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RAD21</i> is called Mungan syndrome [<a class="bk_pop" href="#actg2-dis.REF.bonora.2015.771">Bonora et al 2015</a>]. Bladder involvement has not been reported. Cardiac abnormalities and Barrett esophagus have not been observed in <i>ACTG2-</i> related disorders.</p><p><b><i>CHRM3</i></b><i>.</i> Prune belly syndrome with megacystis has been reported with mutation of <i>CHRM3</i>, a muscarinic acetylcholine receptor subunit. Gastrointestinal symptoms were not reported [<a class="bk_pop" href="#actg2-dis.REF.weber.2005.1036">Weber et al 2005</a>, <a class="bk_pop" href="#actg2-dis.REF.weber.2011.668">Weber et al 2011</a>].</p><p><b><i>CHRNA3</i>,</b>
<b><i>CHRNB2</i>,</b> and <b><i>CHRNB4</i>.</b> Although these nicotinic acetylcholine receptors have not been associated with MMIHS in humans, they may be reasonable candidates based on findings in mouse [<a class="bk_pop" href="#actg2-dis.REF.xu.1999a.5746">Xu et al 1999a</a>, <a class="bk_pop" href="#actg2-dis.REF.xu.1999b.9298">Xu et al 1999b</a>].</p><div id="actg2-dis.Other_Causes_of_Bowel_Obstruct"><h3>Other Causes of Bowel Obstruction</h3><p>In neonates, the clinical presentation of intestinal hypoperistalsis syndrome can mimic other causes of bowel obstruction, such as Hirschsprung disease.</p><p><a href="/books/n/gene/hirschsprung-ov/"><b>Hirschsprung (HSCR) disease</b></a> (or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> intestinal aganglionosis) is characterized by complete absence of neuronal ganglion cells from a portion of the intestinal tract at birth. The aganglionic segment includes the distal rectum and a variable length of contiguous proximal intestine. Rarely, the aganglionosis extends into the small bowel or even more proximally to encompass the entire bowel (total intestinal aganglionosis). HSCR disease may occur as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding or as part of a multisystem disorder. Affected infants frequently present in the first two months of life with findings of impaired intestinal motility such as failure to pass meconium within the first 48 hours of life, constipation, emesis, abdominal pain or distention, and occasionally diarrhea. The finding in HSCR disease that distinguishes it from <i>ACTG2</i>-related disorders is congenital intestinal aganglionosis, characterized by complete absence of neuronal ganglion cells from a portion of the intestinal tract. Additional research is needed to determine if some cases of HSCR can be caused by pathogenic variants of <i>ACTG2</i>.</p><p><a href="/books/n/gene/hirschsprung-ov/"><b>Waardenburg syndrome type IV</b></a>
<b>(WS4)</b> is the combination of pigmentary abnormalities, hearing loss, and Hirschsprung disease [<a class="bk_pop" href="#actg2-dis.REF.jan.2008.744">Jan et al 2008</a>] caused by mutation of one of the following genes: <i>EDNRB</i>, <i>EDN3</i>, or <i>SOX10</i>. Inheritance can be either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (mutation of <i>EDNRB</i>, <i>EDN3</i>, or <i>SOX10</i>) or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (mutation of <i>EDNRB</i> or <i>EDN3</i>).</p></div></div><div id="actg2-dis.Management"><h2 id="_actg2-dis_Management_">Management</h2><div id="actg2-dis.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with an <i>ACTG2</i>-related disorder (which can range from megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) to chronic intestinal pseudoobstruction (CIPO)), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Clinical genetics consultation with complete family history</div></li><li class="half_rhythm"><div><b>Urologic.</b> Consultation with an expert in in pediatric urology whose evaluation may include studies of upper and lower urinary tract and renal function</div></li><li class="half_rhythm"><div><b>Gastrointestinal.</b> Consultation with an expert in pediatric gastroenterology whose evaluation may include radiologic studies of the gastrointestinal tract based on the symptoms and onset. Of note, most individuals with an <i>ACTG2</i>-related disorder will have undergone extensive radiographic imaging prenatally and/or in the neonatal period including evaluation for gastrointestinal distention and/or microcolon. However, if not performed at the time of diagnosis, studies to clarify the extent of disease could include abdominal x-rays, abdominal CT, transit studies (i.e., small bowel contrast studies), and/or endoscopy. Manometry (which typically shows reduced or absent contractions) can be used as an adjunct in the evaluation to quantify the degree of hypoperistalsis and extent of gastrointestinal dysfunction [<a class="bk_pop" href="#actg2-dis.REF.ambartsumyan.2014.16">Ambartsumyan &#x00026; Rodriguez 2014</a>].</div></li><li class="half_rhythm"><div><b>Nutrition.</b> Consultation with a specialist in pediatric nutrition that includes plotting of height and weight on standardized growth charts and assessments of dietary intake, body mass index, and nutritional status (measurement of albumin and prealbumin, and tests of liver function)</div></li></ul></div><div id="actg2-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Children with an <i>ACTG2</i>-related disorder require multidisciplinary management with specialists in pediatric gastroenterology, nutrition, urology, surgery, clinical genetics, and occupational therapy, among others. Adults with an <i>ACTG2</i>-related disorder require similar multidisciplinary care.</p><p>Treatment for <i>ACTG2</i>-related disorders remains supportive.</p><p><b>Urologic manifestations.</b> Management of bladder dysfunction by an urologist is recommended.</p><p>A clear link has been established between fetal urinary tract dilation such as megacystis and long-term impairment of renal function [<a class="bk_pop" href="#actg2-dis.REF.alhazmi.2012.649">Al-Hazmi et al 2012</a>]. Patients are frequently dependent on bladder management with diversion, catheterization, and/or voiding schedules. In addition, clean and safe practices in the use of indwelling intravenous catheters and bladder catheterization can help prevent infections.</p><p>In a review of 14 patients with visceral myopathy evaluated prior to the discovery of <i>ACTG2</i>, <a class="bk_pop" href="#actg2-dis.REF.ghavamian.1997.1286">Ghavamian et al [1997]</a> noted that clean intermittent catheterization decreased the frequency of urinary tract infection and observed that surgical approaches (construction of a catheterizable channel or a vesicostomy) were also therapeutic options.</p><p>In a review of 39 children with CIPO reported before the discovery of <i>ACTG2,</i>
<a class="bk_pop" href="#actg2-dis.REF.lapointe.2002.1768">Lapointe et al [2002]</a> identified megacystis in 26 and hydronephrosis in 14. They noted that urologic intervention to ensure adequate bladder emptying was important to reduce the risk of urinary tract infections and to preserve long-term renal function. Urologic treatment (at some point in their care) included voiding with abdominal pressure (14 children), intermittent catheterization (10), and antibiotic prophylaxis (17).</p><p><b>Gastrointestinal manifestations.</b> Management by a gastroenterologist and nutritionist familiar with intestinal motility disorders is recommended. Patients are frequently dependent on total parenteral nutrition (TPN) (see review by <a class="bk_pop" href="#actg2-dis.REF.gabbard.2013.307">Gabbard &#x00026; Lacy [2013]</a>).</p><p>Complications of long-term TPN can be progressive and include irreversible cholestasis, hepatic dysfunction, central line infections, and thromboembolic events. For this reason, individuals with an intestinal disorder that requires long-term TPN (like those seen in <i>ACTG2</i>-related disorders) have undergone multi-visceral transplantation including liver and intestine. In the series of <a class="bk_pop" href="#actg2-dis.REF.gosemann.2011.1041">Gosemann &#x00026; Puri [2011]</a> in which 12 individuals underwent such multivisceral transplants, TPN could be discontinued in the majority; however, bladder catheterization was still required.</p><p>Isolated intestinal transplantation has also been reported in one individual with MMIHS [<a class="bk_pop" href="#actg2-dis.REF.huang.2013a.e4">Huang et al 2013a</a>].</p><p>Of note, use of pro-kinetic agents such as 5HT<sub>4</sub> agonists has resulted in anecdotal evidence of improvement in bowel function [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>, <a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>], as well as failure to improve in bowel function in MMIHS [<a class="bk_pop" href="#actg2-dis.REF.hiradfar.2013.may31">Hiradfar et al 2013</a>] and some cases of molecularly confirmed <i>ACTG2</i>-related MMIHS [<a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>].</p></div><div id="actg2-dis.Prevention_of_Secondary_Compli"><h3>Prevention of Secondary Complications</h3><p>Establishing the correct diagnosis of an <i>ACTG2</i>-related disorder may help avoid unnecessary exploratory laparotomies for unexplained episodes of apparent intestinal obstruction (i.e., CIPO).</p><p>Surgical procedures associated with general anesthesia can produce a post-surgical ileus which can persist for an extended period.</p><p>Clean and safe practices in the use of indwelling intravenous catheters for administration of TPN and bladder catheterization can help prevent infections.</p></div><div id="actg2-dis.Surveillance"><h3>Surveillance</h3><p>Surveillance should be individualized using a multidisciplinary approach.</p><p>Surveillance should take into account the link between fetal urinary tract dilation and long-term increased risk for impaired renal function [<a class="bk_pop" href="#actg2-dis.REF.alhazmi.2012.649">Al-Hazmi et al 2012</a>].</p><p>Long-term dependence on parenteral nutrition requires routine surveillance of liver function.</p></div><div id="actg2-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>For those with CIPO, high-fat foods (&#x0003e;30% of total calories) and consumption of lactose and fructose may worsen abdominal bloating and discomfort [<a class="bk_pop" href="#actg2-dis.REF.gabbard.2013.307">Gabbard &#x00026; Lacy 2013</a>].</p><p>No drugs are known to exacerbate the smooth muscle functional defect in <i>ACTG2</i>-related disorders.</p></div><div id="actg2-dis.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>Using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to evaluate relatives at risk as early diagnosis may help prevent unnecessary surgery for symptoms of intestinal obstruction and may allow early evaluation of bladder and renal function, and the urinary tract for evidence of dilation.</p><p>See <a href="#actg2-dis.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="actg2-dis.Pregnancy_Management"><h3>Pregnancy Management</h3><p>When a fetus at risk for an <i>ACTG2</i>-related disorder has evidence of bladder distention on prenatal ultrasound examination, consultation with a maternal fetal medicine specialist is recommended. Of note, in some fetuses with prenatal detection of megacystis, vesicoamniotic shunts have been performed. The rationale for this has been questioned [<a class="bk_pop" href="#actg2-dis.REF.tuzovic.2014.74">Tuzovic et al 2014</a>].</p><p>Among the limited number of mothers with an <i>ACTG2</i>-related disorder reported, some instances of poor labor progression and weak uterine contractions have been noted [<a class="bk_pop" href="#actg2-dis.REF.klar.2015.1679">Klar et al 2015</a>].</p></div><div id="actg2-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="actg2-dis.Genetic_Counseling"><h2 id="_actg2-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="actg2-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ACTG2</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="actg2-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with an <i>ACTG2</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Among 23 probands reported to date, six had an affected parent [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>, <a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.klar.2015.1679">Klar et al 2015</a>].</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <i>ACTG2</i>-related disorder may have the condition as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Among the 23 probands reported to date, 14 had a <i>de novo</i> pathogenic variant [<a class="bk_pop" href="#actg2-dis.REF.holla.2014.533">Holla et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.thorson.2014.737">Thorson et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.wangler.2014.e1004258">Wangler et al 2014</a>, <a class="bk_pop" href="#actg2-dis.REF.tuzovic.2015.296">Tuzovic et al 2015</a>]. In two other probands it was unknown if the pathogenic variant was <i>de novo</i> or inherited.</div></li><li class="half_rhythm"><div>If the <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (observed in one of the 23 families reported to date [<a class="bk_pop" href="#actg2-dis.REF.tuzovic.2015.296">Tuzovic et al 2015</a>]).</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include physical examination, a medical history <i>w</i>ith emphasis on signs of intestinal obstruction as an infant and/or chronic constipation, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with an <i>ACTG2</i>-related disorder may appear to be negative because of a milder phenotypic presentation, failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p>Note: If the parent is the individual in whom the <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the <i>ACTG2</i> pathogenic variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>Although <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>ACTG2</i>-related disorders appears to be complete, the severity of clinical findings can vary within a family [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>, <a class="bk_pop" href="#actg2-dis.REF.klar.2015.1679">Klar et al 2015</a>].</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If the <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (observed in one of the 23 families reported to date [<a class="bk_pop" href="#actg2-dis.REF.tuzovic.2015.296">Tuzovic et al 2015</a>]).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with an <i>ACTG2</i>-related disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Although <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>ACTG2</i>-related disorders appears to be complete, the severity of clinical findings can vary within a family.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="actg2-dis.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#actg2-dis.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="actg2-dis.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ACTG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for an <i>ACTG2</i>-related disorder are possible. Note, however, that clinical severity cannot be accurately predicted by family history or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p>Although <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are intellectually normal, <i>ACTG2</i>-related disorders can be severe (e.g., MMIHS) and families may seek <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a>. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="actg2-dis.Resources"><h2 id="_actg2-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International Foundation for Functional Gastrointestinal Disorders (IFFGD)</b></div><div>PO Box 170864</div><div>Milwaukee WI 53217-8076</div><div><b>Phone:</b> 888-964-2001 (toll-free); 414-964-1799</div><div><b>Fax:</b> 414-964-7176</div><div><b>Email:</b> iffgd@iffgd.org</div><div><a href="http://www.iffgd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.iffgd.org</a></div></li><li class="half_rhythm"><div><b>International Foundation for Functional Gastrointestinal Disorders (IFFGD) - Pediatric</b></div><div>PO Box 170864</div><div>Milwaukee WI 53217-8076</div><div><b>Phone:</b> 888-964-2001 (toll-free); 414-964-1799</div><div><b>Fax:</b> 414-964-7176</div><div><b>Email:</b> iffgd@iffgd.org</div><div><a href="http://www.aboutkidsgi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aboutkidsgi.org</a></div></li><li class="half_rhythm"><div><b>National Digestive Diseases Information Clearinghouse (NDDIC)</b></div><div><a href="https://www.niddk.nih.gov/health-information/digestive-diseases/intestinal-pseudo-obstruction" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intestinal Pseudo-obstruction</a></div></li><li class="half_rhythm"><div><b>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</b></div><div>31 Center Drive</div><div>Building 31, Room 9A06</div><div>MSC 2560</div><div>Bethesda MD 20892-2560</div><div><b>Phone:</b> 301-496-3583 </div><div><a href="http://www2.niddk.nih.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www2.niddk.nih.gov</a></div></li><li class="half_rhythm"><div><b>Prune Belly Syndrome Network</b></div><div>P.O. Box 16071</div><div>Philadelphia PA 19154</div><div><b>Phone:</b> 855-ASK-PBSN</div><div><a href="http://prunebelly.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.prunebelly.org</a></div></li><li class="half_rhythm"><div><b>Pull-thru Network (PTN)</b></div><div>2312 Savoy Street</div><div>Hoover AL 35226-1528</div><div><b>Phone:</b> 205-978-2930</div><div><b>Email:</b> PTNmail@charter.net</div><div><a href="http://www.pullthrunetwork.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pullthrunetwork.org</a></div></li></ul></div><div id="actg2-dis.Molecular_Genetics"><h2 id="_actg2-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="actg2-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ACTG2-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299311/table/actg2-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__actg2-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_actg2-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_actg2-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_actg2-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_actg2-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_actg2-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_actg2-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/72" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ACTG2</i></a></td><td headers="hd_b_actg2-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=72" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_actg2-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P63267" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Actin, gamma-enteric smooth muscle</a></td><td headers="hd_b_actg2-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ACTG2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACTG2</a></td><td headers="hd_b_actg2-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ACTG2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACTG2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="actg2-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="actg2-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ACTG2-Related Disorders (<a href="/omim/102545,155310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299311/table/actg2-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__actg2-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/102545" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">102545</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/155310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">155310</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VISCERAL MYOPATHY; VSCM</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>ACTG2</i> spans approximately 27 kb and has a total of nine exons, eight of which are coding. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK299311/#actg2-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date all the pathogenic variants reported in <i>ACTG2</i>-related disorders are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. Many of these affect arginine residues.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>ACTG2</i> encodes &#x003b3;-2 actin, an enteric actin protein.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The abnormal proteins are hypothesized to affect actin filament polymerization and smooth muscle contraction [<a class="bk_pop" href="#actg2-dis.REF.thorson.2014.737">Thorson et al 2014</a>]. Aggregation of the &#x003b3;-2 actin molecules may also occur [<a class="bk_pop" href="#actg2-dis.REF.lehtonen.2012.1482">Lehtonen et al 2012</a>]. Structural data on actin molecules support the role of some of the mutated amino acids in actin polymerization [<a class="bk_pop" href="#actg2-dis.REF.graceffa.2003.34172">Graceffa &#x00026; Dominguez 2003</a>].</p></div><div id="actg2-dis.References"><h2 id="_actg2-dis_References_">References</h2><div id="actg2-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.alhazmi.2012.649">Al-Hazmi H, Dreux S, Delezoide AL, Dommergues M, Lortat-Jacob S, Oury JF, El-Ghoneimi A, Muller F. Outcome of prenatally detected bilateral higher urinary tract obstruction or megacystis: sex-related study on a series of 709 cases. <span><span class="ref-journal">Prenat Diagn. </span>2012;<span class="ref-vol">32</span>:649–54.</span> [<a href="/pubmed/22544566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22544566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.ambartsumyan.2014.16">Ambartsumyan L, Rodriguez L. Gastrointestinal motility disorders in children. <span><span class="ref-journal">Gastroenterol Hepatol (N Y). </span>2014;<span class="ref-vol">10</span>:16–26.</span> [<a href="/pmc/articles/PMC4008955/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4008955</span></a>] [<a href="/pubmed/24799835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24799835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.ballisty.2013.454">Ballisty MM, Braithwaite KA, Shehata B. M, Dickson P. N. Imaging findings in megacystis-microcolon-intestinal hypoperistalsis syndrome. <span><span class="ref-journal">Pediatr Radiol. </span>2013;<span class="ref-vol">43</span>:454–9.</span> [<a href="/pubmed/22926452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22926452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.bonora.2015.771">Bonora E, Bianco F, Cordeddu L, Bamshad M, Francescatto L, Dowless D, Stanghellini V, Cogliandro RF, Lindberg G, Mungan Z, Cefle K, Ozcelik T, Palanduz S, Ozturk S, Gedikbasi A, Gori A, Pippucci T, Graziano C, Volta U, Caio G, Barbara G, D'amato M, Seri M, Katsanis N, Romeo G, De Giorgio R. Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">148</span>:771–82.e11.</span> [<a href="/pmc/articles/PMC4375026/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4375026</span></a>] [<a href="/pubmed/25575569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25575569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.chetaille.2014.1245">Chetaille P, Preuss C, Burkhard S, Cote JM, Houde C, Castilloux J, Piche J, Gosset N, Leclerc S, Wunnemann F, Thibeault M, Gagnon C, Galli A, Tuck E, Hickson GR, El Amine N, Boufaied I, Lemyre E, De Santa Barbara P, Faure S, Jonzon A, Cameron M, Dietz HC, Gallo-Mcfarlane E, Benson DW, Moreau C, Labuda D, Zhan SH, Shen Y, Jomphe M, Jones SJ, Bakkers J, Andelfinger G. Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:1245–9.</span> [<a href="/pubmed/25282101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25282101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.de_giorgio.2011.787">De Giorgio R, Cogliandro RF, Barbara G, Corinaldesi R, Stanghellini V. Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. <span><span class="ref-journal">Gastroenterol Clin North Am. </span>2011;<span class="ref-vol">40</span>:787–807.</span> [<a href="/pubmed/22100118" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22100118</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.fievet.2014.185">Fievet L, Faure A, Coze S, Harper L, Panait N, Braunstein D, Carson J, Gorincour G, Chaumoitre K, Guys JM, Alessandrini P, D'ercole C, Merrot T. Fetal megacystis: etiologies, management, and outcome according to the trimester. <span><span class="ref-journal">Urology. </span>2014;<span class="ref-vol">84</span>:185–90.</span> [<a href="/pubmed/24745800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24745800</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.gabbard.2013.307">Gabbard SL, Lacy BE. Chronic intestinal pseudo-obstruction. <span><span class="ref-journal">Nutr Clin Pract. </span>2013;<span class="ref-vol">28</span>:307–16.</span> [<a href="/pubmed/23612903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23612903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.gargiulo.2007.751">Gargiulo A, Auricchio R, Barone MV, Cotugno G, Reardon W, Milla PJ, Ballabio A, Ciccodicola A, Auricchio A. Filamin A is mutated in X-linked chronic idiopathic intestinal pseudo-obstruction with central nervous system involvement. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:751–8.</span> [<a href="/pmc/articles/PMC1852717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1852717</span></a>] [<a href="/pubmed/17357080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17357080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.gauthier.2015.1266">Gauthier J, Ouled Amar Bencheikh B, Hamdan FF, Harrison SM, Baker LA, Couture F, Thiffault I, Ouazzani R, Samuels ME, Mitchell GA, Rouleau GA, Michaud JL, Soucy JF. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1266–8.</span> [<a href="/pmc/articles/PMC4538215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4538215</span></a>] [<a href="/pubmed/25407000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25407000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.ghavamian.1997.1286">Ghavamian R, Wilcox DT, Duffy PG, Milla PJ. The urological manifestations of hollow visceral myopathy in children. <span><span class="ref-journal">J Urol. </span>1997;<span class="ref-vol">158</span>:1286–90.</span> [<a href="/pubmed/9258196" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9258196</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.gosemann.2011.1041">Gosemann JH, Puri P. Megacystis microcolon intestinal hypoperistalsis syndrome: systematic review of outcome. <span><span class="ref-journal">Pediatr Surg Int. </span>2011;<span class="ref-vol">27</span>:1041–6.</span> [<a href="/pubmed/21792650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21792650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.graceffa.2003.34172">Graceffa P, Dominguez R. Crystal structure of monomeric actin in the ATP state. Structural basis of nucleotide-dependent actin dynamics. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:34172–80.</span> [<a href="/pubmed/12813032" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12813032</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.hiradfar.2013.may31">Hiradfar M, Shojaeian R, Dehghanian P, Hajian S. Megacystis microcolon intestinal hypoperistalsis syndrome. <span><span class="ref-journal">BMJ Case Rep. </span>2013;<span class="ref-vol">2013</span>:May31.</span> [<a href="/pmc/articles/PMC3670043/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3670043</span></a>] [<a href="/pubmed/23729700" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23729700</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.holla.2014.533">Holla OL, Bock G, Busk OL, Isfoss BL. Familial visceral myopathy diagnosed by exome sequencing of a patient with chronic intestinal pseudo-obstruction. <span><span class="ref-journal">Endoscopy. </span>2014;<span class="ref-vol">46</span>:533–7.</span> [<a href="/pubmed/24777424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24777424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.huang.2013a.e4">Huang CM, Tseng SH, Weng CC, Chen Y. Isolated intestinal transplantation for megacystis microcolon intestinal hypoperistalsis syndrome: case report. <span><span class="ref-journal">Pediatr Transplant. </span>2013a;<span class="ref-vol">17</span>:E4–8.</span> [<a href="/pubmed/23167913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23167913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.huang.2013b.699">Huang CM, Wang HM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J. Tumor size as a prognostic factor in patients with node-negative gastric cancer invading the muscularis propria and subserosa (pT2-3N0M0 stage). <span><span class="ref-journal">Hepatogastroenterology. </span>2013b;<span class="ref-vol">60</span>:699–703.</span> [<a href="/pubmed/23159390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23159390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.jan.2008.744">Jan IA, Stroedter L, Haq AU, Din ZU. Association of Shah-Waardenburgh syndrome: a review of 6 cases. <span><span class="ref-journal">J Pediatr Surg. </span>2008;<span class="ref-vol">43</span>:744–7.</span> [<a href="/pubmed/18405726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18405726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.kapur.2010.1528">Kapur RP, Robertson SP, Hannibal MC, Finn LS, Morgan T, Van Kogelenberg M, Loren DJ. Diffuse abnormal layering of small intestinal smooth muscle is present in patients with FLNA mutations and x-linked intestinal pseudo-obstruction. <span><span class="ref-journal">Am J Surg Pathol. </span>2010;<span class="ref-vol">34</span>:1528–43.</span> [<a href="/pubmed/20871226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20871226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.klar.2015.1679">Klar J, Raykova D, Gustafson E, Tothova I, Ameur A, Wanders A, Dahl N. Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1679–83.</span> [<a href="/pmc/articles/PMC4795199/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4795199</span></a>] [<a href="/pubmed/25782675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25782675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.lapointe.2002.1768">Lapointe SP, Rivet C, Goulet O, Fekete CN, Lortat-Jacob S. Urological manifestations associated with chronic intestinal pseudo-obstructions in children. <span><span class="ref-journal">J Urol. </span>2002;<span class="ref-vol">168</span>:1768–70.</span> [<a href="/pubmed/12352356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12352356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.lehtonen.2012.1482">Lehtonen HJ, Sipponen T, Tojkander S, Karikoski R, Jarvinen H, Laing NG, Lappalainen P, Aaltonen LA, Tuupanen S. Segregation of a missense variant in enteric smooth muscle actin gamma-2 with autosomal dominant familial visceral myopathy. <span><span class="ref-journal">Gastroenterology. </span>2012;<span class="ref-vol">143</span>:1482–91.e3.</span> [<a href="/pubmed/22960657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22960657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.mcclelland.2013.271">McClelland C, Walsh RD, Chikwava KR, Johnson MP, Mattei P, Liu GT. Congenital Mydriasis Associated With Megacystis Microcolon Intestinal Hypoperistalsis Syndrome. <span><span class="ref-journal">J Neuroophthalmol. </span>2013;<span class="ref-vol">33</span>:271–5.</span> [<a href="/pubmed/23636104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23636104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.milewicz.2010.2437">Milewicz DM, Ostergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R, Bradley TJ, Olney AH, Ades L, Maher JF, Guo D, Buja LM, Kim D, Hyland JC, Regalado ES. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2437–43.</span> [<a href="/pmc/articles/PMC3573757/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3573757</span></a>] [<a href="/pubmed/20734336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20734336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.puri.2005.58">Puri P, Shinkai M. Megacystis microcolon intestinal hypoperistalsis syndrome. <span><span class="ref-journal">Semin Pediatr Surg. </span>2005;<span class="ref-vol">14</span>:58–63.</span> [<a href="/pubmed/15770589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15770589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.richer.2012.664">Richer J, Milewicz DM, Gow R, De Nanassy J, Maharajh G, Miller E, Oppenheimer L, Weiler G, O'connor M. R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:664–8.</span> [<a href="/pubmed/22302747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22302747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.rudolph.1997.102">Rudolph CD, Hyman PE, Altschuler SM, Christensen J, Colletti RB, Cucchiara S, Di Lorenzo C, Flores AF, Hillemeier AC, McCallum RW, Vanderhoof JA. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>1997;<span class="ref-vol">24</span>:102–12.</span> [<a href="/pubmed/9093995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9093995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.sipponen.2009.437">Sipponen T, Karikoski R, Nuutinen H, Markkola A, Kaitila I. Three-generation familial visceral myopathy with alpha-actin-positive inclusion bodies in intestinal smooth muscle. <span><span class="ref-journal">J Clin Gastroenterol. </span>2009;<span class="ref-vol">43</span>:437–43.</span> [<a href="/pubmed/19098683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19098683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.thorson.2014.737">Thorson W, Diaz-Horta O, Foster J 2nd, Spiliopoulos M, Quintero R, Farooq A, Blanton S, Tekin M. De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis. <span><span class="ref-journal">Hum Genet. </span>2014;<span class="ref-vol">133</span>:737–42.</span> [<a href="/pubmed/24337657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24337657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.tuzovic.2014.74">Tuzovic L, Anyane-Yeboa K, Mills A, Glassberg K, Miller R. Megacystis-microcolon-intestinal hypoperistalsis syndrome: case report and review of prenatal ultrasonographic findings. <span><span class="ref-journal">Fetal Diagn Ther. </span>2014;<span class="ref-vol">36</span>:74–80.</span> [<a href="/pubmed/24577413" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24577413</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.tuzovic.2015.296">Tuzovic L, Tang S, Miller RS, Rohena L, Shahmirzadi L, Gonzalez K, Li X, Leduc CA, Guo J, Wilson A, Mills A, Glassberg K, Rotterdam H, Sepulveda AR, Zeng W, Chung WK, Anyane-Yeboa K. New insights into the genetics of fetal megacystis: ACTG2 mutations, encoding x03B3;-2 smooth muscle actin in megacystis microcolon intestinal hypoperistalsis syndrome (Berdon syndrome). <span><span class="ref-journal">Fetal Diagn Ther. </span>2015;<span class="ref-vol">38</span>:296–306.</span> [<a href="/pubmed/25998219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25998219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.wangler.2014.e1004258">Wangler MF, Gonzaga-Jauregui C, Gambin T, Penney S, Moss T, Chopra A, Probst FJ, Xia F, Yang Y, Werlin S, Eglite I, Kornejeva L, Bacino CA, Baldridge D, Neul J, Lehman EL, Larson A, Beuten J, Muzny DM, Jhangiani S, Gibbs RA, Lupski JR, Beaudet A. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome. <span><span class="ref-journal">PLoS Genet. </span>2014;<span class="ref-vol">10</span>:e1004258.</span> [<a href="/pmc/articles/PMC3967950/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3967950</span></a>] [<a href="/pubmed/24676022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24676022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.weber.2005.1036">Weber S, Mir S, Schlingmann KP, Nurnberg G, Becker C, Kara PE, Ozkayin N, Konrad M, Nurnberg P, Schaefer F. Gene locus ambiguity in posterior urethral valves/prune-belly syndrome. <span><span class="ref-journal">Pediatr Nephrol. </span>2005;<span class="ref-vol">20</span>:1036–42.</span> [<a href="/pubmed/15912376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15912376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.weber.2011.668">Weber S, Thiele H, Mir S, Toliat MR, Sozeri B, Reutter H, Draaken M, Ludwig M, Altmuller J, Frommolt P, Stuart HM, Ranjzad P, Hanley NA, Jennings R, Newman WG, Wilcox DT, Thiel U, Schlingmann KP, Beetz R, Hoyer PF, Konrad M, Schaefer F, Nurnberg P, Woolf AS. Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:668–74.</span> [<a href="/pmc/articles/PMC3213389/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213389</span></a>] [<a href="/pubmed/22077972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22077972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.xu.1999a.5746">Xu W, Gelber S, Orr-Urtreger A, Armstrong D, Lewis RA, Ou CN, Patrick J, Role L, De Biasi M, Beaudet AL. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1999a;<span class="ref-vol">96</span>:5746–51.</span> [<a href="/pmc/articles/PMC21931/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC21931</span></a>] [<a href="/pubmed/10318955" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10318955</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="actg2-dis.REF.xu.1999b.9298">Xu W, Orr-Urtreger A, Nigro F, Gelber S, Sutcliffe CB, Armstrong D, Patrick JW, Role LW, Beaudet AL, De Biasi M. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. <span><span class="ref-journal">J Neurosci. </span>1999b;<span class="ref-vol">19</span>:9298–305.</span> [<a href="/pmc/articles/PMC6782888/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6782888</span></a>] [<a href="/pubmed/10531434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10531434</span></a>]</div></li></ul></div></div><div id="actg2-dis.Chapter_Notes"><h2 id="_actg2-dis_Chapter_Notes_">Chapter Notes</h2><div id="actg2-dis.Author_Notes"><h3>Author Notes</h3><p><b>Web pages</b></p><ul><li class="half_rhythm"><div><a href="http://www.texaschildrens.org/find-a-doctor/michael-f-wangler-md" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.texaschildrens.org/find-a-doctor/michael-f-wangler-md</a></div></li><li class="half_rhythm"><div><a href="https://www.bcm.edu/people/view/arthur-beaudet-m-d/b15432e4-ffed-11e2-be68-080027880ca6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">https://www.bcm.edu/people/view/arthur-beaudet-m-d</a></div></li></ul><p><b>Authors' research.</b> The authors are currently using the latest technology including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> to understand rare mendelian disorders including disorders of intestinal motility.</p></div><div id="actg2-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 June 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>15 July 2014 (mw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK299311</span><span class="label">PMID: <a href="/pubmed/26072522" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26072522</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dupl22q11/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/adamtsl4-eyes/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK299311&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK299311/?report=reader">PubReader</a></li><li><a href="/books/NBK299311/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK299311" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK299311" style="display:none" title="Cite this Page"><div class="bk_tt">Wangler MF, Beaudet AL. ACTG2-Related Disorders. 2015 Jun 11. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK299311/pdf/Bookshelf_NBK299311.pdf">PDF version of this page</a> (467K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#actg2-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#actg2-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#actg2-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#actg2-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#actg2-dis.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#actg2-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#actg2-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#actg2-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#actg2-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#actg2-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#actg2-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#actg2-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=72[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ACTG2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4077760" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4077760" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4077760" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4077760" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25998219" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).</a><span class="source">[Fetal Diagn Ther. 2015]</span><div class="brieflinkpop offscreen_noflow">New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tuzovic L, Tang S, Miller RS, Rohena L, Shahmirzadi L, Gonzalez K, Li X, LeDuc CA, Guo J, Wilson A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Fetal Diagn Ther. 2015; 38(4):296-306. Epub 2015 May 13.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29387497" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Novel Mutation in ACTG2 Gene in Mother with Chronic Intestinal Pseudoobstruction and Fetus with Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.</a><span class="source">[Case Rep Genet. 2017]</span><div class="brieflinkpop offscreen_noflow">A Novel Mutation in ACTG2 Gene in Mother with Chronic Intestinal Pseudoobstruction and Fetus with Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Whittington JR, Poole AT, Dutta EH, Munn MB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Case Rep Genet. 2017; 2017:9146507. Epub 2017 Dec 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27481187" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.</a><span class="source">[Am J Med Genet A. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moreno CA, Metze K, Lomazi EA, Bertola DR, Barbosa RH, Cosentino V, Sobreira N, Cavalcanti DP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2016 Nov; 170(11):2965-2974. Epub 2016 Aug 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29781137" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.</a><span class="source">[Neurogastroenterol Motil. 2018]</span><div class="brieflinkpop offscreen_noflow">Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ravenscroft G, Pannell S, O'Grady G, Ong R, Ee HC, Faiz F, Marns L, Goel H, Kumarasinghe P, Sollis E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurogastroenterol Motil. 2018 Sep; 30(9):e13371. Epub 2018 May 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23967498" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Urofacial Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Urofacial Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Newman WG, Woolf AS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26072522" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26072522" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d1075f66d18aa91f3e2">ACTG2-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ACTG2-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:29:52-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88DCB3E03FCDC1000000000627023A&amp;ncbi_session=CE88DCB3E040D0F1_1575SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK299311%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK299311&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK299311/&amp;ncbi_pagename=ACTG2-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88DCB3E040D0F1_1575SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>